ARCHIVES

NCI brings in grantees to explain their work, promise of nanotech, to advisory board.

This article is from The Cancer Letter archive.

Vol. 30 No. 29 | July 16, 2004

Download PDF Visit The Full Archive

Related Articles

HCFA Firm Against Reimbursement For Patients In Clinical Trials, Lasagna Committee Hears

March 24, 1989

American Home Products Changes Name To Wyeth.

March 1, 2002

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Richard Wood, ICRF, Accepts Appointment At Pittsburgh.

March 2, 2001

NCI CTEP-Approved Trials For the Month of October

October 31, 2014

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002